Adial Pharmaceuticals Inc. |

Portfolio Categories Past Media

-1

archive,tax-portfolio_category,term-past-media,term-99,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

Archive

29 Apr Adial Pharmaceutical’s Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate

28 Feb William Stilley, CEO of Adial Pharmaceuticals (NASDAQ: ADIL) sits down with BAF host Michelle Griego to discuss the company’s lead asset, AD04, as a potential genetically targeted treatment for alcohol and opioid use disorder.

04 Feb William Stilley, President and Chief Executive Officer, on the KSWB-TV FOX 5 Morning News in San Diego to discussing AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder

11 Jan Adial’s Dr. Bankole Johnson Featured on The Doctors Channel discussing medicinal approaches to alcohol use disorder.

16 Nov Alcoholism: Is there a medicinal solution on the horizon? EHealth Radio invited Adial’s CEO, William Stilley, for an interview. Listen to the interview to learn more!

10 Oct Treating Addiction Through Neuroscience Breakthroughs, with Prof. Bankole Johnson of the University of Maryland School of Medicine | EDB 72